Picture of Cell Bio Human Tech Co logo

318160 Cell Bio Human Tech Co Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
Consumer CyclicalsSpeculativeMicro CapSuper Stock

Annual cashflow statement for Cell Bio Human Tech Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUSARSAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line4,2153,1132,890-1,8574,379
Depreciation
Amortisation
Non-Cash Items1,4433,7051,5322,410-715
Unusual Items
Other Non-Cash Items
Changes in Working Capital-3,087-743-5,842-5963,700
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities3,7237,6144411,7609,271
Capital Expenditures-13,249-3,850-375-1,133-2,026
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items13,294-6864,3943,762-2,617
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities45.1-4,5354,0202,630-4,643
Financing Cash Flow Items-13,996-6,000-5
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-8,3204,317-13,895-4,832-5,623
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-4,6197,676-9,434-442-953